References
- Wang J, Liu W, Yu D, et al. Research progress on the treatment of premature ovarian failure using mesenchymal stem cells: a literature review. Front Cell Dev Biol. 2021;9:1. doi: 10.3389/fcell.2021.749822.
- Liu L, Wang H, Xu GL, et al. Tet1 deficiency leads to premature ovarian failure. Front Cell Dev Biol. 2021;9:644135. doi: 10.3389/fcell.2021.644135.
- Ghahremani-Nasab M, Ghanbari E, Jahanbani Y, et al. Premature ovarian failure and tissue engineering. J Cell Physiol. 2020;235(5):4217–9. doi: 10.1002/jcp.29376.
- Pandey AK, Gupta A, Tiwari M, et al. Impact of stress on female reproductive health disorders: Possible beneficial effects of shatavari (Asparagus racemosus). Biomed Pharmacother. 2018;103:46–49. doi: 10.1016/j.biopha.2018.04.003.
- Lin L, Gao W, Chen Y, et al. Reactive oxygen species-induced SIAH1 promotes granulosa cells’ senescence in premature ovarian failure. J Cell Mol Med. 2022;26(8):2417–2427. doi: 10.1111/jcmm.17264.
- Prasad S, Tiwari M, Pandey AN, et al. Impact of stress on oocyte quality and reproductive outcome. J Biomed Sci. 2016;23:36. doi: 10.1186/s12929-016-0253-4.
- Yadav AK, Yadav PK, Chaudhary GR, et al. Autophagy in hypoxic ovary. Cell Mol Life Sci CMLS. 2019;76(17):3311–3322. doi: 10.1007/s00018-019-03122-4.
- Tamura H, Jozaki M, Tanabe M, et al. Importance of melatonin in assisted reproductive technology and ovarian aging. Int J Mol Sci. 2020;21(3). doi: 10.3390/ijms21031135.
- Yong W, Ma H, Na M, et al. Roles of melatonin in the field of reproductive medicine. Biomed Pharmacother. 2021;144:112001. doi: 10.1016/j.biopha.2021.112001.
- Tsiligiannis S, Panay N, Stevenson JC. Premature ovarian insufficiency and long-term health consequences. Curr Vasc Pharmacol. 2019;17(6):604–609. doi: 10.2174/1570161117666190122101611.
- An R, Wang X, Yang L, et al. Polystyrene microplastics cause granulosa cells apoptosis and fibrosis in ovary through oxidative stress in rats. Toxicology. 2021;449:152665. doi: 10.1016/j.tox.2020.152665.
- Yang H, Xie Y, Yang D, et al. Oxidative stress-induced apoptosis in granulosa cells involves JNK, p53 and Puma. Oncotarget. 2017;8(15):25310–25322. doi: 10.18632/oncotarget.15813.
- Kuang J, Chen L, Tang Q, et al. The role of Sirt6 in obesity and diabetes. Front Physiol. 2018;9:135. doi: 10.3389/fphys.2018.00135.
- Liu G, Chen H, Liu H, et al. Emerging roles of SIRT6 in human diseases and its modulators. Med Res Rev. 2021;41(2):1089–1137. doi: 10.1002/med.21753.
- Grootaert MOJ, Finigan A, Figg NL, et al. SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis. Circ Res. 2021;128(4):474–491. doi: 10.1161/CIRCRESAHA.120.318353.
- Ru M, Wang W, Zhai Z, et al. Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells. Food Funct. 2022;13(14):7507–7519. doi: 10.1039/d2fo00525e.
- Li L, Chen B, An T, et al. BaZiBuShen alleviates altered testicular morphology and spermatogenesis and modulates Sirt6/P53 and Sirt6/NF-κB pathways in aging mice induced by D-galactose and NaNO(2). J Ethnopharmacol. 2021;271:113810. doi: 10.1016/j.jep.2021.113810.
- Zhang J, Fang L, Lu Z, et al. Are sirtuins markers of ovarian aging? Gene. 2016;575(2 Pt 3):680–686. doi: 10.1016/j.gene.2015.09.043.
- Wei H, Khawar MB, Tang W, et al. Sirt6 is required for spermatogenesis in mice. Aging. 2020;12(17):17099–17113. doi: 10.18632/aging.103641.
- Huang Z, Zhao J, Deng W, et al. Identification of a cellularly active SIRT6 allosteric activator. Nat Chem Biol. 2018;14(12):1118–1126. doi: 10.1038/s41589-018-0150-0.
- Yan Z, Dai Y, Fu H, et al. Curcumin exerts a protective effect against premature ovarian failure in mice. J Mol Endocrinol. 2018;60(3):261–271. doi: 10.1530/JME-17-0214.
- Jin J, Li W, Wang T, et al. Loss of proximal tubular sirtuin 6 aggravates unilateral ureteral obstruction-induced tubulointerstitial inflammation and fibrosis by regulation of β-catenin acetylation. Cells. 2022;11(9). doi: 10.3390/cells11091477.
- Kasapoğlu I, Seli E. Mitochondrial dysfunction and ovarian aging. Endocrinology. 2020;161(2):1–11. doi: 10.1210/endocr/bqaa001.
- Yang Q, Mumusoglu S, Qin Y, et al. A kaleidoscopic view of ovarian genes associated with premature ovarian insufficiency and senescence. FASEB J Off Publ Federation Am Soc Exp Biol. 2021;35(8):e21753. doi: 10.1096/fj.202100756R.
- Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, et al. Autoimmune diseases in patients with premature ovarian insufficiency-our current state of knowledge. Int J Mol Sci. 2021;22(5):2594. doi: 10.3390/ijms22052594.
- Ding T, Yan W, Zhou T, et al. Endocrine disrupting chemicals impact on ovarian aging: evidence from epidemiological and experimental evidence. Environ Pollut. 2022;305:119269. doi: 10.1016/j.envpol.2022.119269.
- Anagnostis P, Paschou SA, Katsiki N, et al. Menopausal hormone therapy and cardiovascular risk: where are we now? Curr Vasc Pharmacol. 2019;17(6):564–572. doi: 10.2174/1570161116666180709095348.
- Saha S, Roy P, Corbitt C, et al. Application of stem cell therapy for infertility. Cells. 2021;10(7):1613. doi: 10.3390/cells10071613.
- Liang X, Yan Z, Ma W, et al. Peroxiredoxin 4 protects against ovarian ageing by ameliorating D-galactose-induced oxidative damage in mice. Cell Death Dis. 2020;11(12):1053. doi: 10.1038/s41419-020-03253-8.
- Ruth KS, Day FR, Hussain J, et al. Genetic insights into biological mechanisms governing human ovarian ageing. Nature. 2021;596(7872):393–397. doi: 10.1038/s41586-021-03779-7.
- Jiang JY, Cheung CK, Wang Y, et al. Regulation of cell death and cell survival gene expression during ovarian follicular development and atresia. Front Biosci J Virtual Library. 2003;8:d222–d237.
- Matsuda F, Inoue N, Manabe N, et al. Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells. J Reprod Dev. 2012;58(1):44–50. doi: 10.1262/jrd.2011-012.
- Guan Y, Zhang W, Wang X, et al. Cell-free DNA induced apoptosis of granulosa cells by oxidative stress. Clin Chim Acta Int J Clin Chem. 2017;473:213–217. doi: 10.1016/j.cca.2016.11.023.
- Hoque SAM, Umehara T, Kawai T, et al. Adverse effect of superoxide-induced mitochondrial damage in granulosa cells on follicular development in mouse ovaries. Free Rad Biol Med. 2021;163:344–355. doi: 10.1016/j.freeradbiomed.2020.12.434.
- Shen M, Jiang Y, Guan Z, et al. Protective mechanism of FSH against oxidative damage in mouse ovarian granulosa cells by repressing autophagy. Autophagy. 2017;13(8):1364–1385. doi: 10.1080/15548627.2017.1327941.
- Zhang S, Liu Q, Chang M, et al. Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis. Cell Death Dis. 2023;14(5):340. doi: 10.1038/s41419-023-05859-0.
- Liu M, Liang K, Zhen J, et al. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nat Commun. 2017;8(1):413. doi: 10.1038/s41467-017-00498-4.
- Mishra M, Duraisamy AJ, Bhattacharjee S, et al. Adaptor protein p66Shc: a link between cytosolic and mitochondrial dysfunction in the development of diabetic retinopathy. Antioxid Redox Signal. 2019;30(13):1621–1634. doi: 10.1089/ars.2018.7542.
- Haslem L, Hays JM, Hays FA. p66Shc in cardiovascular pathology. Cells. 2022;11(11):1855. doi: 10.3390/cells11111855.
- Boengler K, Bornbaum J, Schlüter KD, et al. P66shc and its role in ischemic cardiovascular diseases. Basic Res Cardiol. 2019;114(4):29. doi: 10.1007/s00395-019-0738-x.
- Pinton P, Rizzuto R. p66Shc, oxidative stress and aging: importing a lifespan determinant into mitochondria. Cell Cycle (Georgetown, Tex). 2008;7(3):304–308. doi: 10.4161/cc.7.3.5360.
- Wang D, Wang T, Wang R, et al. Suppression of p66Shc prevents hyperandrogenism-induced ovarian oxidative stress and fibrosis. J Transl Med. 2020;18(1):84. doi: 10.1186/s12967-020-02249-4.
- Onnis A, Cassioli C, Finetti F, et al. Regulation of selective B CELL autophagy by the pro-oxidant adaptor p66SHC. Front Cell Dev Biol. 2020;8:193. doi: 10.3389/fcell.2020.00193.